Immucell (ICCC) traded down -1.82 % during a 24 hours period ending at 07:38 PM Central Europe on Monday 26th. One Immucell stock can currently be bought for about USD 10.21 on popular exchanges. Current supply of Immucell stocks is 9.1 mn. Immucell has a current market capitalization of USD 93.1 mn and approximately USD 115.8 k worth of Immucell was traded on exchanges in the last 24 hours. Since last month end, Immucell has traded 2.81 % up. Simple moving average of last 200 days is at USD 8.77. The highest price of past 52 weeks was recorded at USD 12.1 on 07/14/2026. 52 weeks low was at USD 4.52 on 11/21/2025.

Here is how related stocks have performed in the past 24 hours:

  • Arc Securities Ac (FJDIU) traded up 0.2 % and now trades at USD 10.05. Current market capitalisation for Arc Securities Ac is USD 111.2 mn.

  • Minerva Neurosciences (NERV) traded down -4.17 % and now trades at USD 2.24. Current market capitalisation for Minerva Neurosciences is USD 109.8 mn.

  • Seer (SEER) traded flat 0 % and now trades at USD 1.94. Current market capitalisation for Seer is USD 109.1 mn. SEER INC’s share price has experienced a modest, gradual upward trend over the past month, reflecting steady investor confidence in the company’s ongoing developments. The market reaction appears to be linked to recent disclosures regarding SEER’s pipeline progress and strategic partnerships, which have reinforced expectations of future growth. Trading activity has remained relatively stable, with moderate volumes that support the price movement without generating sharp volatility. Analysts note that the company’s focus on advancing its technology platform and expanding its customer base aligns with broader industry momentum. While no significant corporate action or earnings report has been released during this period, the consistent price improvement suggests that SEER INC continues to maintain a positive perception among market participants.

  • Mobile Infrastructure (BEEP) traded down -1.54 % and now trades at USD 2.55. Current market capitalisation for Mobile Infrastructure is USD 111.3 mn.

  • Commercial Vehicle (CVGI) traded up 4.35 % and now trades at USD 2.94. Commercial Vehicle has a market capitalisation of USD 109.4 mn.

About Immucell

ImmuCell Corporation is a biotechnology company based in Portland, United States, which specializes in developing and manufacturing milk-derived passive antibody products. These products are aimed at preventing and/or treating gastrointestinal infections in both humans and animals. Additionally, through joint ventures, the company entered into a UK distribution agreement to market Crypto-Scan, a drinking-water test. ImmuCell also produces bovine lactoferrin. The website for the company is www.immucell.com , and they are listed on the Nasdaq stock exchange. Their Initial Public Offering (IPO) date is from April 1987.